4.6 Article

Stop the beat to see the rhythm: excitation-contraction uncoupling in cardiac research

Journal

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpheart.00477.2021

Keywords

blebbistatin; cardiac physiology; excitation-contraction uncoupler; optical mapping

Funding

  1. National Heart, Lung, and Blood Institute (NHLBI) [HL139472, HL111600, HL146169, HL147279]
  2. Children's Research Institute
  3. Children's National Heart Institute
  4. University of California Tobacco Related Disease Research Program Grant [T29IP0365C]

Ask authors/readers for more resources

Optical mapping is a valuable imaging technique used in cardiovascular research to study electrophysiology and excitation-contraction coupling of cardiac tissues. The use of excitation-contraction uncoupling agents, such as blebbistatin, can help reduce signal distortion, but may have secondary effects on cardiac electrical activity and metabolic demand. It is essential to carefully consider the potential risks and best practices when using blebbistatin in optical mapping studies of cardiac tissue.
Optical mapping is an imaging technique that is extensively used in cardiovascular research, wherein parameter-sensitive fluorescent indicators are used to study the electrophysiology and excitation-contraction coupling of cardiac tissues. Despite many benefits of optical mapping, eliminating motion artifacts within the optical signals is a major challenge, as myocardial contraction interferes with the faithful acquisition of action potentials and intracellular calcium transients. As such, excitation-contraction uncoupling agents are frequently used to reduce signal distortion by suppressing contraction. When compared with other uncoupling agents, blebbistatin is the most frequently used, as it offers increased potency with minimal direct effects on cardiac electrophysiology. Nevertheless, blebbistatin may exert secondary effects on electrical activity, metabolism, and coronary flow, and the incorrect administration of blebbistatin to cardiac tissue can prove detrimental, resulting in erroneous interpretation of optical mapping results. In this Getting It Right perspective, we briefly review the literature regarding the use of blebbistatin in cardiac optical mapping experiments, highlight potential secondary effects of blebbistatin on cardiac electrical activity and metabolic demand, and conclude with the consensus of the authors on best practices for effectively using blebbistatin in optical mapping studies of cardiac tissue.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available